Cases & Deals

  • Home
  • Practices
  • Merck develops global patent portfolio related to certain antibodies for treatment of cognitive disorders

Share

Merck develops global patent portfolio related to certain antibodies for treatment of cognitive disorders

March 2021

Client(s) Merck & Co., Inc.

Jones Day is representing Merck & Co., Inc. in the development and prosecution of global patent portfolios related to certain antibodies that are being developed for the treatment and prevention of various cognitive disorders.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.